TS-066751 — In the rapidly evolving field of biotechnology and pharmaceuticals, there is a critical need for efficient delivery mechanisms to transport therapeutic agents directly into cells. Traditional methods face challenges with membrane impermeability and degradation of therapeutic compounds, limiting th…

TS-062617 — The Need: In today's fast-paced world, effective drug delivery remains a paramount challenge in achieving therapeutic outcomes. Pharmaceutical industries and researchers are in pursuit of innovative technologies to overcome cellular barriers and deliver therapeutic agents precisely. Addressing t…

TS-062439 — The Need: Addressing the Growing Threat of Gram-Negative Bacterial Infections Gram-negative bacterial pathogens, including Escherichia coli, Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae, are responsible for more than 35% of common hospital-acquired infections. These no…

TS-062425 — The Need: In the world of healthcare, there is a critical need for a nutritional supplement that can effectively strengthen and promote general health, especially for individuals with limited food intake and compromised ability to absorb nutrients. Patients undergoing bariatric surgery, chemothera…

TS-062420 — The Need: Addressing Nutritional Challenges in Cystic Fibrosis Cystic Fibrosis (CF) presents significant nutritional challenges for individuals living with the condition. Due to the increased energy requirements and difficulties in nutrient absorption, CF patients often struggle to maintain adequat…

TS-050433 — A gene therapy solution for Usher Syndrome Type 1F.

TS-037675 — Novel method of using live attenuated vaccines to prevent infection of hMVP.

TS-037664 — A live recombinant vesicular stomatitis virus (VSV)-vector vaccine composition for human norovirus.